Agios Pharmaceuticals | Zahlungsmittel Und Äquivalente



Cash And Equivalent Veränderung Datum
AbbVie USD 5.18B 349M 2025-03
Agios Pharmaceuticals USD 80.87M 1.91M 2025-06
Alnylam Pharmaceuticals USD 1.11B 94.03M 2025-06
Amgen USD 8.03B 782M 2025-06
Arrowhead Research USD 129.79M 55.92M 2025-06
Astellas Pharma JPY 188.37B 8.51B 2025-03
AstraZeneca USD 7.06B 1.83B 2025-06
Bayer EUR 4.56B 542M 2025-06
Biogen USD 2.76B 160.5M 2025-06
BioMarin Pharmaceutical USD 1.21B 601.78M 2025-06
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
Daiichi Sankyo JPY 639.84B 42.31B 2025-03
Eli Lilly USD 3.38B 282.6M 2025-06
Exelixis USD 164.43M 19.32M 2025-06
Gilead Sciences USD 5.14B 2.78B 2025-06
GlaxoSmithKline GBP 3.6B 865M 2025-06
Incyte USD 2.42B 13.08M 2025-06
Ionis Pharmaceuticals USD 297.3M 33.11M 2025-06
Merck USD 8.01B 622M 2025-06
Moderna USD 1.28B 344M 2025-06
Novartis USD 6.66B 410M 2025-06
Novartis USD 11.46B 2.15B 2024-12
Pfizer USD 1.64B 208M 2025-06
Regeneron Pharmaceuticals USD 2B 1.09B 2025-06
Roche Holding CHF 6.98B 2.15B 2024-12
Sarepta Therapeutics USD 510.6M 269.73M 2025-06
Vertex Pharmaceuticals USD 6.38B 1.71B 2025-06


Agios Pharmaceuticals Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.